P13K/AKT crosstalk with ER-signaling and cell survival
P13K/AKT 串扰与 ER 信号传导和细胞存活
基本信息
- 批准号:6993557
- 负责人:
- 金额:$ 29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-02-18 至 2008-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The primary long-term objective of this research is to understand the role of AKT-signaling cross-talk with the estrogen receptor (ER) in the control of cell survival and in the development of anti-estrogen resistance. We hypothesize that the AKT pathway functions to target and phosphorylate the p160 coactivator GRIP and ER proteins leading to regulation of CoA-recruitment, receptor-activation and gene expression. We further hypothesize that convergence of the AKT and estrogen signaling at the ER-CoA-transcriptional level is critical in the regulation of cell survival and influences selective estrogen receptor modulator (SERM) activity in hormone dependent cell systems such as breast carcinoma. The Specific Aims are proposed to 1) Determine the mechanisms of AKT-ER cross-talk by examining specific targeting, phosphorylation and activation of ER-AF2 and/or the p160 CoA GRIP by AKT and 2) Determine the physiological relevance of this cross-talk by examining effects of AKT-ER-CoA on the regulation of endogenous estrogen-responsive genes, alteration of SERM-activity and gene expression, and long-term cell survival. Specific Aim #1, To determine the role of AKT targeting and phosphorylation of ER-AF2 as a mechanism for cross-talk. We propose to determine if the ER-AF2 targeting occurs through direct phosphorylation by AKT and the role of specific phosphorylation sites in AKT-ER cross-talk. Specific Aim #2, To implicate AKT regulation of p160 coactivator-(GRIP) phosphorylation as a mechanism for activation of and recruitment to estrogen receptors. Studies will determine if AKT phosphorylates and activates GRIP though specific targeting of the GRIP-NRID (nuclear receptor interaction domain) or GRIP-AD2 (activation domain-2) as mechanisms for AKT regulation of GRIP in control of ER transcription. Specific Aim #3, to determine the requirement for GRIP phosphorylation/function in AKT-mediated regulation of ER-dependent cell survival, gene expression and SERM activity. In this aim, we will determine the role for specific AKT induced ER-CoA recruitment/activation in the regulation of cell survival gene expression (Bcl-2) and the influence of AKT-ER-CoA cross-talk on SERM activity. These studies will also determine if the mechanisms for AKT-phosphorylation of ER or GRIP from above are critical in the AKT-ER mediated regulation of cell survival. It is expected as a whole that this proposal will establish the mechanisms used by the investigator3K-AKT cascade to target the ER and the subsequent components of the ER transcription complex required for potentiation of activity by this pathway. This cross-talk and the mechanisms identified will be used to establish the biological relevancy of the pathway in terms of cell survival and altered SERM activity.
描述(由申请人提供):本研究的主要长期目标是了解akt信号与雌激素受体(ER)的串扰在控制细胞存活和抗雌激素抗性发展中的作用。我们假设AKT通路的功能是靶向p160共激活因子GRIP和ER蛋白并使其磷酸化,从而调控辅酶a的募集、受体激活和基因表达。我们进一步假设,AKT和雌激素信号在er - coa转录水平上的趋同对细胞存活的调节至关重要,并影响乳腺癌等激素依赖细胞系统中选择性雌激素受体调节剂(SERM)的活性。本文提出的具体目标是:1)通过检测AKT对ER-AF2和/或p160 CoA GRIP的特异性靶向、磷酸化和激活来确定AKT- er串扰的机制;2)通过检测AKT- er -CoA对内源性雌激素应答基因的调节、serm活性和基因表达的改变以及细胞长期存活的影响来确定这种串扰的生理相关性。特异性目的1:确定AKT靶向和ER-AF2磷酸化作为串扰机制的作用。我们建议通过AKT的直接磷酸化以及AKT- er串扰中特定磷酸化位点的作用来确定ER-AF2靶向是否发生。目的2:揭示AKT调控p160共激活因子-(GRIP)磷酸化作为雌激素受体激活和募集的机制。研究将确定AKT是否通过特异性靶向GRIP- nrid(核受体相互作用结构域)或GRIP- ad2(激活结构域-2)磷酸化并激活GRIP,作为AKT调控GRIP控制ER转录的机制。具体目的#3,确定GRIP磷酸化/功能在akt介导的er依赖性细胞存活、基因表达和SERM活性调节中的需求。为此,我们将确定特异性AKT诱导的ER-CoA募集/激活在调节细胞存活基因(Bcl-2)表达中的作用,以及AKT-ER-CoA串导对SERM活性的影响。这些研究还将确定akt磷酸化ER或GRIP的机制在AKT-ER介导的细胞存活调节中是否至关重要。总体而言,我们预计该提案将建立研究者3k - akt级联所使用的机制,以靶向内质网和内质网转录复合体的后续组分,这些组分需要通过该途径增强活性。这种串扰和确定的机制将用于确定该途径在细胞存活和改变SERM活性方面的生物学相关性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew E. Burow其他文献
Obesity-associated epigenetic alterations and the obesity-breast cancer axis
肥胖相关的表观遗传改变与肥胖-乳腺癌轴
- DOI:
10.1038/s41388-024-02954-0 - 发表时间:
2024-02-03 - 期刊:
- 影响因子:7.300
- 作者:
Courtney B. Lagarde;Joachim Kavalakatt;Megan C. Benz;Mackenzie L. Hawes;Carter A. Arbogast;Nicole M. Cullen;Emily C. McConnell;Caroline Rinderle;Katherine L. Hebert;Maninder Khosla;Jorge A. Belgodere;Van T. Hoang;Bridgette M. Collins-Burow;Bruce A. Bunnell;Matthew E. Burow;Suresh K. Alahari - 通讯作者:
Suresh K. Alahari
Role of Nischarin in the pathology of diseases: a special emphasis on breast cancer
尼施林在疾病病理学中的作用:特别强调乳腺癌
- DOI:
10.1038/s41388-021-02150-4 - 发表时间:
2022-01-22 - 期刊:
- 影响因子:7.300
- 作者:
Samuel C. Okpechi;Hassan Yousefi;Khoa Nguyen;Thomas Cheng;Nikhilesh V. Alahari;Bridgette Collins-Burow;Matthew E. Burow;Suresh K. Alahari - 通讯作者:
Suresh K. Alahari
Endocrine disrupters and flavonoid signalling
内分泌干扰物与类黄酮信号传导
- DOI:
10.1038/35093163 - 发表时间:
2001-09-13 - 期刊:
- 影响因子:48.500
- 作者:
Jennifer E. Fox;Marta Starcevic;Kelvin Y. Kow;Matthew E. Burow;John A. McLachlan - 通讯作者:
John A. McLachlan
The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer
- DOI:
10.1007/s10555-022-10063-1 - 发表时间:
2022-08-24 - 期刊:
- 影响因子:8.700
- 作者:
Bruce A. Bunnell;Elizabeth C. Martin;Margarite D. Matossian;Courtney K. Brock;Khoa Nguyen;Bridgette Collins-Burow;Matthew E. Burow - 通讯作者:
Matthew E. Burow
Matthew E. Burow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew E. Burow', 18)}}的其他基金
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer
用于研究癌症中 NEK 激酶家族的化学探针的鉴定和表征
- 批准号:
10503430 - 财政年份:2022
- 资助金额:
$ 29万 - 项目类别:
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer (Diversity Supplement - Belgodere)
用于询问癌症中 NEK 激酶家族的化学探针的鉴定和表征(多样性补充 - Belgodere)
- 批准号:
10745843 - 财政年份:2022
- 资助金额:
$ 29万 - 项目类别:
Characterization of an understudied kinase, NEK5, in acquisition of a mesenchymaland migratory cell phenotype
一种正在研究的激酶 NEK5 在获取间充质细胞和迁移细胞表型中的表征
- 批准号:
10047560 - 财政年份:2020
- 资助金额:
$ 29万 - 项目类别:
P13K/AKT crosstalk with ER-signaling and cell survival
P13K/AKT 串扰与 ER 信号传导和细胞存活
- 批准号:
7163550 - 财政年份:2003
- 资助金额:
$ 29万 - 项目类别:
P13K/AKT crosstalk with ER-signaling and cell survival
P13K/AKT 串扰与 ER 信号传导和细胞存活
- 批准号:
6849312 - 财政年份:2003
- 资助金额:
$ 29万 - 项目类别:
相似海外基金
Harnessing PET to Study the In Vivo Fate and Health Effects of Micro- and Nanoplastics
利用 PET 研究微塑料和纳米塑料的体内命运和健康影响
- 批准号:
10890903 - 财政年份:2023
- 资助金额:
$ 29万 - 项目类别:
Altered microglia states and microglia-endothelial cell axis in relation to white matter disease progression in VCID
VCID 中小胶质细胞状态和小胶质细胞内皮细胞轴的改变与白质疾病进展相关
- 批准号:
10738860 - 财政年份:2023
- 资助金额:
$ 29万 - 项目类别:
Subtype-Selective Metabotropic Glutamate Receptor PET Ligands
亚型选择性代谢型谷氨酸受体 PET 配体
- 批准号:
10576674 - 财政年份:2023
- 资助金额:
$ 29万 - 项目类别:
Circadian Rhythms in Blood Brain Barrier Permeability and Increased Efficacy of Chemotherapy for Brain Metastases
血脑屏障通透性的昼夜节律和脑转移化疗疗效的提高
- 批准号:
10663717 - 财政年份:2023
- 资助金额:
$ 29万 - 项目类别:
Glycogen synthase kinase 3 ligand discovery for Alzheimer’s disease
糖原合成酶激酶 3 配体发现治疗阿尔茨海默病
- 批准号:
10637434 - 财政年份:2023
- 资助金额:
$ 29万 - 项目类别:
Assessing Diffusion MRI Metrics for Detecting Changes of Synaptic Density in Alzheimer's Disease
评估弥散 MRI 指标以检测阿尔茨海默病突触密度的变化
- 批准号:
10739911 - 财政年份:2023
- 资助金额:
$ 29万 - 项目类别:
Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers
支持在吸烟者 2 期临床研究中评估 mGlu2 PAM SBP-9330 的安全性/毒理学、ADME 和 CMC 活动
- 批准号:
10829189 - 财政年份:2023
- 资助金额:
$ 29万 - 项目类别:
Probing D2 and 5HT-2A mechanisms in early visual processing in V1
探索 V1 早期视觉处理中的 D2 和 5HT-2A 机制
- 批准号:
10605769 - 财政年份:2023
- 资助金额:
$ 29万 - 项目类别:
Develop in vivo PET imaging probes for ROCK2 as a biomarker of early Alzheimer's disease.
开发 ROCK2 的体内 PET 成像探针作为早期阿尔茨海默病的生物标志物。
- 批准号:
489145 - 财政年份:2023
- 资助金额:
$ 29万 - 项目类别:
Operating Grants














{{item.name}}会员




